Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA bans Red Dye 3
FDA bans Red No. 3 food dye in food, drinks: Here's what to know
The FDA announced on Wednesday that it has banned the use of Red No. 3, an additive used to give food and drinks a cherry-red color.
FDA Bans Red Dye No. 3 From Foods
Food and Drug Administration officials granted a 2022 petition filed by two dozen food safety and health advocates.
FDA Bans Red No. 3, Leaving 8 Synthetic Dyes In America’s Food
With Wednesday's ban of Red No. 3, there are now 8 artificial dyes in America's food supply. Discover what dyes remain, the health risk to humans, and the companies involved.
FDA Approves Niktimvo 9 Mg And 22 Mg Vial Sizes
Eli Lilly Receives FDA Approval for Crohn’s Disease Treatment
Eli Lilly said it received Food and Drug Administration approval for its treatment for moderate to severely-active Crohn’s disease, an inflammatory bowel disease that causes chronic abdominal pain.
Incyte's and Syndax's Graft Disease Treatment Niktimvo Gets FDA Approval for Vial Sizes
Incyte has exclusive commercialization rights for Niktimvo outside the U.S. Niktimvo was approved by the FDA on Aug. 14 for the treatment of chronic graft-versus-host disease after failure of at least two prior lines of systemic therapy in adult and pediatric patients weighing at least 40 kilograms.
Incyte, Syndax get FDA okay for 9 mg, 22 mg Niktimvo vials
Incyte (NASDAQ:INCY) and Syndax Pharmaceuticals (SNDX) have received FDA approval for their drug Niktimvo in 9 mg and 22 mg vial sizes. Niktimvo was approved in August 2024 for the treatment of chronic graft-versus-host disease after failure of at least two prior lines of systemic therapy in adult and pediatric patients weighing at least 40 kg,
2h
on MSN
US FDA approves expanded use of Lilly's bowel disease drug
Eli Lilly said on Wednesday the U.S. health regulator has approved its drug to treat adults with moderate-to-severe Crohn's ...
BioPharma Dive
12h
Federal watchdog cites concerns with FDA’s accelerated approval process
The review, which was spurred by controversy over the FDA's Aduhelm approval, recommends two main changes in agency ...
11h
on MSN
Only FDA-approved vape products are available for purchase in Kentucky. Here's what to know
In 2024, the General Assembly passed House Bill 11, which limits vape products that can be sold in Kentucky.
4d
FDA Approves Weight-loss Drug Zepbound For Sleep Apnea – Will Insurance Cover This $1000-Per-Month Medication?
Zepbound is a dual-activating medication that combines glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like ...
2d
on MSN
Billed as nonaddictive, new pain pill could soon win FDA approval
A non-opioid painkiller from Vertex Pharmaceuticals could become a blockbuster, but questions remain on whether it will prove ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback